Through the decreased expression of PI3KR1, AKT1, and BCL2 mRNA levels compared with control group, we demonstrated that the inhibition of hepatocellular carcinoma by aloe-emodin could be mediated through the PI3K-AKT signaling pathway. Here, BCL2 is linked to hepatocellular carcinoma.